August 19, 2017

TOP CORPORATE NEWS

NHPC receives environmental clearance for Dibang project

NHPC has received environmental clearance for its Dibang multipurpose hydropower cum flood moderation project (2880 MW), worth over Rs25,000 crore, in Arunachal Pradesh – positive for NHPC.

GAIL signs preliminary deal with Shell for sale of LNG

GAIL has signed a preliminary deal with Shell for the potential sale of liquefied natural gas ( LNG) supply sourced from its portfolio, made up of US production.

Claris Life sciences surges on sale of injectible biz reports

Shares of Claris Life sciences jumped 12% to Rs313 on the BSE, accompanied by heavy volumes, after an Economic Times report suggested that Cadila Healthcare has emerged as the front runner to acquire the generic sterile injectables business of the company.The stock turned volatile after opening at Rs323 on the BSE. It has touched high of Rs 331 and low of Rs 300 so far.

Glenmark gets tentative ANDA approval for Rufinamide Tablets USP

Glenmark Pharmaceuticals has been granted tentative approved last week by United States Food & Drug Administration (US FDA) for its Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel Tablets of Eisai, Inc. Under the terms of settlement agreement between Glenmark and Eisai, Glenmark will be permitted to market this product in the United States on May 30, 2022 or potentially earlier under certain circumstances.

Godrej Prop sells over 200 apts at launch of Godrej icon

Mumbai-based real estate developer, Godrej Properties”);’> Godrej Properties said that it has sold over 200 apartments of its recently launched residential project Godrej Icon, in Sector 89A/88A, Gurgaon. The company has sold over 200 apartments, with an area over 400,000 sq. ft. in just three weeks at the launch of its residential project, Godrej Icon, in Sector 89A/88A, Gurgaon, the company said.

Strides to buy generic Pharma biz in Australia

Strides Arcolab  announced that Strides Pharma Global, Singapore and Strides (Australia) Pharma, Australia, both subsidiaries of Strides Arcolab have signed definitive agreements with certain wholly owned subsidiaries of Aspen Pharmacies Holdings, a company listed on the Johannesburg Stock Exhchange (Aspen), to acquire a generic pharmaceutical business in Australia together with certain branded pharmaceutical asset.

PTC India to call for bids from solar project developers

As part of the government’s plan to push solar electricity by paying for it in dollars, power trading company PTC India Ltd may call for bids from solar project developers on behalf of the ministry of new and renewable energy (MNRE) denominated in dollar. With PTC (major power trading company) making a purchase guarantee, these projects will become bankable and help solar power reach grid parity. Positive read through for the renewable power sector, especially solar power.

CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. CapitalStars also aveliable on twitterlinkedin & facebook.

CapitalStars is a research house and an investment advisory company carrying out operations in the Indian Equities and commodity market. We generate intraday as well as delivery calls in Stock cash and F&O in NSE & BSE, Commodities including bullions, metals & Agro- commodities traded in MCX and NCDEX.

CapitalStars King investment advisory tips provider which is including Equity King ,Bullion King & Agri King from commodity, equity & stock market.

Capital Stars

Comments are closed.

NOTE : You are advised to take your position with your sense and judgment.The views and investment tips expressed by users on MCXStar.com are their own, and not that of the website or its management. MCXStar.com advises users to check with certified experts before taking any investment decisions. If any other company also giving same script and recommandation then we are not responsible for that. We have not any position in our given scripts. Visiting our web one should by agree to our terms and condition and disclaimer also. All credit goes to original authors of post on this website. Website owner is not responsible for any loss due to your own decision or judgement. Thanks for Visiting our Website.